£10k to invest? 2 penny stocks to buy after recent falls

I’m searching for the best value penny stocks to buy following share price reversals. Here are two that have caught my eye recently.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I think these penny stocks are top buys following recent share price weakness. Here’s why I think they could boost my wealth.

Mega cheap on paper

Investors have been turned off by Venture Life Group (LSE: VLG) in recent months and its share price has slumped. The business manufactures a range of non-prescription healthcare products and demand for its hand sanitisers has slumped in line with global Covid-19 infection rates. This penny stock is now 53% cheaper than it was a year ago.

I think this weakness provides a great dip-buying opportunity though. After all, Venture Life now trades on a forward price-to-earnings growth (PEG) ratio of 0.3. This is inside the accepted benchmark of 1 that suggests a stock could be undervalued.

Acquisitions to fuel growth?

I like Venture Life because of its commitment to expansion and the success of its acquisition strategy. City analysts believe the stock’s earnings will rebound 35% in 2022 and latest financials in January underlined its solid outlook.

Back then, Venture Life said that second-half sales were up 35% from the first six months of 2021. It added that the order book was “significantly ahead” of levels reported a year earlier. I’m also encouraged by its deal with Samarkand Global to sell its oral products like Dentyl mouthwash in China. Disappointing sales from its previous partner there compounded the firm’s woes last year.

Venture Life is a highly cash-generative business and has plenty of liquidity to pursue acquisitions following a revolving credit facility it sealed in mid-2021. An acquisition-led growth strategy can throw up problems like poor sales and unexpected costs later down the line. But as a long-term investor I find its commitment to supercharge profits through M&A very attractive.

Another great dip buy

Assura Group (LSE: AGR) is another penny stock that’s fallen heavily over the past year. Despite a recent recovery, the healthcare property specialist trades at a 6% discount to levels recorded this time last March. I’m also considering snapping it up today.

Assura doesn’t exactly look cheap based on current earnings forecasts. The business trades on a price-to-earnings (P/E) ratio of 21.6 times for the financial year beginning in April. However, its jumbo 4.6% dividend yield is what makes it an attractive buy for me at current prices.

A rock-solid penny stock

I have to say I believe that Assura deserves that premium P/E ratio, anyway. It’s never going to deliver explosive earnings growth — City analysts are forecasting a 6% profits rise in the year to March 2023 — but the ultra-defensive nature of its operations make it a fantastic investment in my book.

Assura develops and then lets out primary healthcare facilities. This is a part of the property market that delivers stable rents at all point of the economic cycle. In fact, demand for such buildings should keep rising steadily as Britain’s population ages and the need for healthcare infrastructure subsequently increases.

Future changes to government health policy could hit earnings one day. But as things stand now, I think Assura is a great buy, and especially for those seeking passive income with dividend shares.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »